182 related articles for article (PubMed ID: 19638648)
21. Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa.
Lince-Deroche N; van Rensburg C; Roseleur J; Sanusi B; Phiri J; Michelow P; Smith JS; Firnhaber C
PLoS One; 2018; 13(10):e0203921. PubMed ID: 30308014
[TBL] [Abstract][Full Text] [Related]
22. Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation.
Peron M; Llewellyn A; Moe-Byrne T; Walker S; Walton M; Harden M; Palmer S; Simmonds M
Health Technol Assess; 2018 Sep; 22(54):1-260. PubMed ID: 30284968
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
Kaufman RH; Adam E; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
[TBL] [Abstract][Full Text] [Related]
24. Cost-Effectiveness Analysis of Different Management Strategies for Detection CIN2+ of Women with Atypical Squamous Cells of Undetermined Significance (ASC-US) Pap Smear in Thailand.
Tantitamit T; Termrungruanglert W; Oranratanaphan S; Niruthisard S; Tanbirojn P; Havanond P
Asian Pac J Cancer Prev; 2015; 16(16):6857-62. PubMed ID: 26514457
[TBL] [Abstract][Full Text] [Related]
25. Management of women with mild and moderate cervical dyskaryosis.
Flannelly G; Anderson D; Kitchener HC; Mann EM; Campbell M; Fisher P; Walker F; Templeton AA
BMJ; 1994 May; 308(6941):1399-403. PubMed ID: 8019248
[TBL] [Abstract][Full Text] [Related]
26. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.
Lince-Deroche N; Phiri J; Michelow P; Smith JS; Firnhaber C
PLoS One; 2015; 10(11):e0141969. PubMed ID: 26569487
[TBL] [Abstract][Full Text] [Related]
27. Impact of post-colposcopy management on women's long-term worries: results from the UK population-based TOMBOLA trial.
Sharp L; Cotton S; Cruickshank M; Gray N; Smart L; Whynes D; Little J;
J Fam Plann Reprod Health Care; 2016 Jan; 42(1):43-51. PubMed ID: 26376822
[TBL] [Abstract][Full Text] [Related]
28. Every woman with an abnormal cervical smear should be referred for treatment: debate.
Flannelly G; Kitchener H
Clin Obstet Gynecol; 1995 Sep; 38(3):585-91. PubMed ID: 8612368
[TBL] [Abstract][Full Text] [Related]
29. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.
Karnon J; Peters J; Platt J; Chilcott J; McGoogan E; Brewer N
Health Technol Assess; 2004 May; 8(20):iii, 1-78. PubMed ID: 15147611
[TBL] [Abstract][Full Text] [Related]
30. Impact of patient adherence and test performance on the cost-effectiveness of cervical cancer screening in developing countries: the case of Honduras.
Perkins RB; Langrish SM; Stern LJ; Burgess JF; Simon CJ
Womens Health Issues; 2010; 20(1):35-42. PubMed ID: 19944623
[TBL] [Abstract][Full Text] [Related]
31. The short-term financial costs of abnormal Pap smears to women and government in Australia.
Kavanagh AM; Butler JR
Aust N Z J Public Health; 1998; 22(3 Suppl):347-52. PubMed ID: 9629821
[TBL] [Abstract][Full Text] [Related]
32. On-site colposcopy services in a family practice residency clinic: impact on physician test-ordering behavior, patient compliance, and practice revenue generation.
Prislin MD; Dinh T; Giglio M
J Am Board Fam Pract; 1997; 10(4):259-64. PubMed ID: 9228620
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women.
Dempster-Rivett K; Innes CR; Simcock BJ; Harker D; Williman JA; Van Der Griend RA; Whitehead M; Hibma M; Lawton BA; Fitzgerald P; Dudley NM; Petrich S; Faherty J; Bergzoll C; Eva L; Sadler L; Pather S; Wrede CD; Sykes PH
Am J Obstet Gynecol; 2020 Sep; 223(3):408.e1-408.e11. PubMed ID: 32109465
[TBL] [Abstract][Full Text] [Related]
34. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
[TBL] [Abstract][Full Text] [Related]
36. Should liquid-based cytology be performed prior to colposcopy? A comparison of the accuracy, unsatisfactory rates and cost in a tertiary referral setting.
Angstetra D; Tait T; Tan J; Symonds I
Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):681-4. PubMed ID: 20070723
[TBL] [Abstract][Full Text] [Related]
37. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
Martin-Hirsch P; Rash B; Martin A; Standaert B
BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
[TBL] [Abstract][Full Text] [Related]
38. Repeat cervical cytology at the time of colposcopy. Is there an added benefit?
Simsir A; Ioffe OB; Bourquin P; Brooks SE; Henry M
Acta Cytol; 2001; 45(1):23-7. PubMed ID: 11213500
[TBL] [Abstract][Full Text] [Related]
39. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the TOMBOLA randomised controlled trial.
Sharp L; Cotton S; Little J; Gray NM; Cruickshank M; Smart L; Thornton A; Waugh N; Walker L;
PLoS One; 2013; 8(12):e80092. PubMed ID: 24386076
[TBL] [Abstract][Full Text] [Related]
40. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK.
Brown RE; Breugelmans JG; Theodoratou D; Bénard S
Curr Med Res Opin; 2006 Apr; 22(4):663-70. PubMed ID: 16684427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
